Pharmacology 102 (3-4), 196205
Unlike past diet and weight-loss trends, GLP-1 receptor agonist drugs are generating levels of enthusiasm that have rarely been seen
Multiple reviewers praised the guidance received from their doctors, nutritionist support and affordability
Sleep deprivation impairs insulin secretion and glucose tolerance, contributing to T2DM risk [50]
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Analysis And Forecast 2026 To 2035 Obesity Treatment Market Size and Growth Factors 2026 to 2035 The global obesity treatment market size reached USD 18.90 billion in 2025 and is expected to be worth around USD 112.87 billion by 2035, exhibiting at a compound annual growth rate (CAGR) of 19.57% over the forecast period 2026 to 2035